Universal Neonatal Hearing Screening: An Experience at Tertiary Care Hospital

B L Shrestha1, S Karmacharya1, A Dhakal1

  • 1Department of ENT-HNS, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal.

Insights

Automated Auditory Brainstem Response (AABR) effectively screens newborn hearing. Early AABR screening and intervention are crucial for preventing long-term hearing loss in infants.

Area of Science:

  • Pediatric Audiology
  • Neonatal Health
  • Public Health Screening

Background:

  • Congenital hearing loss is a significant pediatric health concern, often undetected early.
  • Universal screening, diagnosis, and intervention are vital for mitigating the impact of neonatal hearing loss.

Purpose of the Study:

  • To evaluate the effectiveness of Automated Auditory Brainstem Response (AABR) for hearing screening in newborns.
  • To assess hearing outcomes in neonates admitted to the intensive care unit (NICU) at Dhulikhel Hospital.

Main Methods:

  • A prospective study screened 5517 neonates using AABR within 24 hours of birth and at 6 weeks if initial screening failed.
  • NICU neonates were assessed for risk factors according to the Joint Committee on Infant Hearing guidelines.
  • Babies failing the second screening were referred for comprehensive audiological diagnostic workup.

Main Results:

  • A 92.6% screening rate was achieved. 6.7% of screened neonates (374/5517) required referral after the second screening.
  • Among referred neonates, 6.59% were well babies and 9% were NICU babies.
  • Common risk factors included low birth weight, prematurity, hyperbilirubinemia, ototoxic medication use, and prolonged mechanical ventilation.

Conclusions:

  • Automated Auditory Brainstem Response (AABR) is a valuable tool for neonatal hearing screening.
  • Screening within the first month of life and timely intervention for confirmed hearing loss are recommended for improved future hearing outcomes.